Takeda looks to Russia to lead emerging markets growth
This article was originally published in Scrip
Executive Summary
News of a factory opening in Russia may conjure up visions of Soviet-era tractor quotas, but Takeda sees its €75 million investment in a high-tech pharmaceutical plant in Yaroslavl as reflecting the growth potential of the country's open commercial market.